2 Year Efficiency and Safety Comparison of Insulin Detemir and NPH Insulin [insulin-suspension-isophane] in Type 1 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Insulin detemir; Insulin suspension isophane
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 07 Jun 2017 Biomarkers information updated
- 07 Jul 2009 Actual patient number changed from 497 to 501 as reported by ClinicalTrials.gov.
- 07 Jul 2009 Actual end date (Sep 2006) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History